Efficacy and safety of full-length pegylated recombinant factor VIII with extended half-life in previously treated patients with hemophilia A: comparison of data between the general and Japanese study populations
Nogami, Keiji, Shima, Midori, Fukutake, Katsuyuki, Fujii, Teruhisa, Taki, Masashi, Matsushita, Tadashi, Higasa, Satoshi, Sato, Tetsuji, Sakai, Michio, Arai, Morio, Uchikawa, Haruhiko, Engl, Werner, AbLanguage:
english
Journal:
International Journal of Hematology
DOI:
10.1007/s12185-017-2265-6
Date:
May, 2017
File:
PDF, 478 KB
english, 2017